U.S. markets open in 3 hours 31 minutes

Bio-Rad Laboratories, Inc. (BIO-B)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
497.860.00 (0.00%)
At close: 10:04AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Gap Up

Gap Up

Previous Close471.62
Bid201.95 x 1400
Ask807.77 x 800
Day's Range494.67 - 494.67
52 Week Range465.00 - 818.60
Avg. Volume81
Market Cap14.89B
Beta (5Y Monthly)0.92
PE Ratio (TTM)N/A
EPS (TTM)-3.39
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-15% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BIO-B

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Bio-Rad Laboratories, Inc.
    PKI: Raising target price to $148.00PERKINELMER INC has an Investment Rating of HOLD; a target price of $148.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
  • Insider Monkey

    Investors are Watching These 10 Biotech Stocks

    In this article, we discuss the 10 biotech stocks that investors are watching. If you want to read about some more biotech stocks, go directly to Investors are Watching These 5 Biotech Stocks. The stock market plunge in the past few weeks because of soaring inflation and a hawkish central bank has also resulted in […]

  • Business Wire

    Bio-Rad Publishes Corporate Sustainability Report

    HERCULES, Calif., June 27, 2022--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today released its inaugural corporate sustainability report.

  • Simply Wall St.

    Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?

    Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...